These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11281476)

  • 1. Can a cyclo-oxygenase type-2 selective tocolytic agent avoid the fetal side effects of indomethacin?
    Locatelli A; Vergani P; Bellini P; Strobelt N; Ghidini A
    BJOG; 2001 Mar; 108(3):325-6. PubMed ID: 11281476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe oligohydramnios induced by cyclooxygenase-2 inhibitor nimesulide.
    Holmes RP; Stone PR
    Obstet Gynecol; 2000 Nov; 96(5 Pt 2):810-1. PubMed ID: 11094215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin inhibitors as tocolytic agents.
    Vermillion ST; Landen CN
    Semin Perinatol; 2001 Aug; 25(4):256-62. PubMed ID: 11561913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anhydramnios and maternal thrombocytopenia after prolonged use of nimesulide.
    Paternoster DM; Snijders D; Manganelli F; Torrisi A; Bracciante R
    Eur J Obstet Gynecol Reprod Biol; 2003 May; 108(1):97-8. PubMed ID: 12694979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin inhibitors in preterm labour.
    Loudon JA; Groom KM; Bennett PR
    Best Pract Res Clin Obstet Gynaecol; 2003 Oct; 17(5):731-44. PubMed ID: 12972011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience of the use of nimesulide, a cyclo-oxygenase-2 selective prostaglandin synthesis inhibitor, in the prevention of preterm labour in 44 high-risk cases.
    Sawdy RJ; Groom KM; Bennett PR
    J Obstet Gynaecol; 2004 Apr; 24(3):226-9. PubMed ID: 15203612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effect of cyclo-oxygenase inhibitors with different isoform selectivity in lipopolysaccharide-induced preterm birth in mice.
    Lee PR; Kim SR; Jung BK; Kim KR; Chung JY; Won HS; Kim A
    Am J Obstet Gynecol; 2003 Jul; 189(1):261-6. PubMed ID: 12861172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tocolysis: an update for the practitioner.
    Rodts-Palenik S; Morrison JC
    Obstet Gynecol Surv; 2002 May; 57(5 Suppl 2):S9-34. PubMed ID: 12000859
    [No Abstract]   [Full Text] [Related]  

  • 9. Good fetal outcome following prolonged indomethacin induced anhydramnios. Case report.
    Shen O; Rabinowitz R; Lavie O; Aboulafia Y; Diamant YZ
    J Perinat Med; 1995; 23(3):233-6. PubMed ID: 8568616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligohydramnios induced by maternal indomethacin therapy.
    Uslu T; Ozcan FS; Aydin C
    Int J Clin Pharmacol Ther Toxicol; 1992 Jul; 30(7):230-2. PubMed ID: 1506126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind randomized study of fetal side effects during and after the short-term maternal administration of indomethacin, sulindac, and nimesulide for the treatment of preterm labor.
    Sawdy RJ; Lye S; Fisk NM; Bennett PR
    Am J Obstet Gynecol; 2003 Apr; 188(4):1046-51. PubMed ID: 12712108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a cyclo-oxygenase type-2-selective non-steroidal anti-inflammatory agent to prevent preterm delivery.
    Sawdy R; Slater D; Fisk N; Edmonds DK; Bennett P
    Lancet; 1997 Jul; 350(9073):265-6. PubMed ID: 9242810
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro study of tocolytic effect of rofecoxib, a specific cyclo-oxygenase 2 inhibitor. Comparison and combination with other tocolytic agents.
    Doret M; Mellier G; Benchaib M; Piacenza JM; Gharib C; Pasquier JC
    BJOG; 2002 Sep; 109(9):983-8. PubMed ID: 12269693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective randomized safety trial of celecoxib for treatment of preterm labor.
    Stika CS; Gross GA; Leguizamon G; Gerber S; Levy R; Mathur A; Bernhard LM; Nelson DM; Sadovsky Y
    Am J Obstet Gynecol; 2002 Sep; 187(3):653-60. PubMed ID: 12237643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal end-stage renal failure associated with maternal ingestion of cyclo-oxygenase-type-1 selective inhibitor nimesulide as tocolytic.
    Peruzzi L; Gianoglio B; Porcellini MG; Coppo R
    Lancet; 1999 Nov; 354(9190):1615. PubMed ID: 10560684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety of prolonged indomethacin therapy.
    Savage AH; Anderson BL; Simhan HN
    Am J Perinatol; 2007 Apr; 24(4):207-13. PubMed ID: 17447185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized comparative trial of indomethacin and ritodrine for the long-term treatment of preterm labor.
    Besinger RE; Niebyl JR; Keyes WG; Johnson TR
    Am J Obstet Gynecol; 1991 Apr; 164(4):981-6; discussion 986-8. PubMed ID: 2014850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the tocolytic effect of a selective cyclooxygenase-2 inhibitor in a mouse model of lipopolysaccharide-induced preterm delivery.
    Sakai M; Tanebe K; Sasaki Y; Momma K; Yoneda S; Saito S
    Mol Hum Reprod; 2001 Jun; 7(6):595-602. PubMed ID: 11385116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of acute low back pain with the COX-2-selective anti-inflammatory drug nimesulide: results of a randomized, double-blind comparative trial versus ibuprofen.
    Pohjolainen T; Jekunen A; Autio L; Vuorela H
    Spine (Phila Pa 1976); 2000 Jun; 25(12):1579-85. PubMed ID: 10851109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of short-term indomethacin therapy on amniotic fluid volume.
    Sandruck JC; Grobman WA; Gerber SE
    Am J Obstet Gynecol; 2005 May; 192(5):1443-5. PubMed ID: 15902132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.